1 recruiting, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Recruiting 1, Terminated 1 |
Follow Mesothelin-expressing Advanced Cancers: new trials by email Literature Review of Mesothelin-expressing Advanced Cancers trials Research Report on Mesothelin-expressing Advanced Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CT-95 in Advanced Cancers Associated With Mesothelin Expression CT-95 - Mesothelin-Expressing Tumors, Epithelial Ovarian Cancer | Phase 1 | Recruiting | Context Therapeutics Inc. | 70 | 2025-03-31 | 2026-06-12 |
| A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers ZW171 - Mesothelin-expressing Advanced Cancers | Phase 1 | Terminated | Zymeworks BC Inc. | 32 | 2024-09-30 | 2025-10-21 |
Neoplasms (2) · Carcinoma, Ovarian Epithelial (1) · Colorectal Neoplasms (1) · Mesothelioma, Malignant (1) · Neoplasm Metastasis (1)
Adenoma (1) · Adnexal Diseases (1) · Carcinoma (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1)
Context Therapeutics Inc. (1) · Zymeworks BC Inc. (1)
United States (2) · Germany (1) · South Korea (1) · United Kingdom (1)
Karen Chagin, MD (1) · Pranshul Chauhan, MSc, MB, BCh, BAO (1)